CHICAGO: Suven Life Sciences Ltd said a drug being developed by the company to treat Alzheimer’s disease is now being tested in multiple doses among volunteers, having passed the single-dose stage.

Suven said that the drug candidate called SUVN-G3031 is undergoing a so-called Phase-1 study Read More »

ROCHESTER: Arts and crafts, such as pottery, knitting, woodworking and painting, could be good hobbies to pick up in middle age. According to new research, middle-age and older adults who partake in these type of activities regularly may reduce their risk of developing the thinking Read More »

COLORADO SPRINGS: A drug is under development that could be used as an adjunct to anti-psychotics improved cognitive impairment in patients with schizophrenia, according to data from a randomized, controlled Phase II trial.

Encenicline, which is being developed by Forum Pharmaceuticals, is intended to address Read More »

NEW YORK: GreyMatters is an iPad app that is portable, easy-to-use technology that could help younger family members have more meaningful interactions with older relatives suffering from dementia. It is available to download for free from the iTunes Store…

Full story covered in the Dementia